ArticleJournal of gastrointestinal oncology2021

Apatinib plus S-1 for previously treated, advanced gastric or gastro-oesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study.

Chao Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.